Authors: O. Klepáčková; M. Tomka Authors‘ workplace: Katedra sociální práce, Vysoká škola polytechnická Jihlava Published in: Klin Onkol 2025; 38(Supplementum 1): 108-113 Category: Article doi: https://doi.org/10.48095/ccko2024S108
Background: Oncological disease is characterized not only by the initial loss of health resulting from the diagnosis itself, but also by secondary losses that affect the areas of physical, emotional, spiritual, and social life. These phenomena are associated with the patients’ and their families’ living conditions; however, they can also manifest in a highly personal and intimate manner, even at the existential level. The topic remains understudied even in the international context. Material and methods: The research group of the study, conducted from July 2024 to May 2025, consisted of 10 oncological patients. The study’s ethical considerations are noteworthy: the patients were not newly diagnosed, hospitalized, or experiencing an acute psychological crisis. Semi-structured interviews were analyzed using interpretative phenomenological analysis. The group size and homogeneity were defined according to the research method’s principles. Results: The study identified a range of secondary losses, which included short-term, long-term, permanent, and threatening losses. These losses were found to be interconnected and cumulative, often proving to be more intense than the primary loss of health itself. Secondary losses have frequently been underestimated and overlooked in terms of their significance and impact. Insufficient attention has been paid to the experience of loneliness and isolation, often compounded by feelings of shame or guilt. Additionally, the loss of fellow patients was another experience that often went neglected. Conclusion: For oncological patients, the loss of health is just the beginning of multiple significant losses they face. The patient’s experience of secondary losses can affect the treatment and quality of life during and after treatment. The burden of these losses is a critical factor in identifying vulnerable patients who may develop serious psychosocial conditions.
Quality of life – cancer – interpretative phenomenological analysis – psychosocial intervention – life changes – secondary losses – disease trajectory
1. Obispo B, Cruz-Castellanos P, Hernandez R et al. Perceived dignity of advanced cancer patients and its relationship to sociodemographic, clinical, and psychological factors. Front Psychol 2022; 13 : 855704. doi: 10.3389/fpsyg 2022.855704/j.radonc.2016.03.011.
2. Rodríguez-Prat A, Pergolizzi D, Crespo I et al. Control in patients with advanced cancer: an interpretative phenomenological study. BMC Palliat Care 2022; 21 (1): 97. doi: 10.1186/s12904-022-00984-7.
3. Lond B, Apps L, Quincey K et al. The psychological impact of living with peritoneal mesothelioma: An interpretative phenomenological analysis. J Health Psychol 2024. [In press]. doi: 10.1177/13591053241 298932
4. Werner-Lin A, Young JL, Wilsnack C et al. Waiting and “weighted down”: the challenge of anticipatory loss for individuals and families with Li-Fraumeni Syndrome. Fam Cancer 2020; 19 (3): 259–268. doi: 10.1007/s10689-020-00173-6.
5. Bencová V, Bella V, Švec J. Dynamika vývoja psychosociálnej záťaže prežívajúcich pacientok s karcinómom prsníka: klinický úspech s psychosociálnymi dôsledkami. Klin Onkol 2011; 24 (3): 203–208. doi: 10.14735/amko2011203.
6. Kolsteren EE, Deuning-Smith E, Chu AK et al. Psychosocial aspects of living long term with advanced cancer and ongoing systemic treatment: a scoping review. Cancers 2022; 14 (16): 3889. doi.org/10.3390/cancers14163889
7. Adam Z, Klimeš J, Boleloucký Z. Sociální a psychické vlivy na průběh nemoci. Onkologie 2022; 16 (Suppl. 8): 103–110. doi: 10.36290/xon.2022.059.
8. Pospíchal M. Psychoonkologie. Praha: Grada Publishing 2024.
9. Angenendt G, Schütze-Kreilkamp U, Tschuschke V. Psychoonkologie v praxi: psychoedukace, poradenství a terapie. Praha: Portál 2010.
10. Svoboda M, Halámková J et al. Péče o pacienty po ukončení kurativní onkologické léčby. Praha: Grada Publishing 2023.
11. Kupka M. Psychosociální aspekty paliativní péče. Psyché. Praha: Grada Publishing 2014.
12. Harris D. Non-death loss and grief: context and clinical implications. New York: Routledge 2019.
13. Lazarus RS, Folkman S. Stress, appraisal, and coping. New York: Springer Publishing Company 1986.
14. Allan B, Shearer B. The Scale for Existential Thinking. International Journal of Transpersonal Studies 2012; 31 (1): 21–37. doi: 10.24972/ijts.2012.31.1.21.
15. Caplan C. Principles of preventive psychiatry. New York: Basic Books 1964.
16. Taku K, Tedeschi RG, Shakespeare-Finch J et al. Posttraumatic growth (PTG) and posttraumatic depreciation (PTD) across ten countries: global validation of the PTG-PTD theoretical model. Personality and Individual Differences 2021; 169 : 110222. doi: 10.1016/j.paid.2020.110222.
17. Power M, Bullinger M, Harper A. The World Health Organization WHOQOL-100: Tests of the universality of quality of life in 15 different cultural groups worldwide. Health Psychol 1999; 18 (5): 495–505. doi: 10.1037/0278-6133.18.5.495.
18. NANDA International. Ošetřovatelské diagnózy Definice a klasifikace 2018–2020 Praha: Grada 2020.
19. Christ GH, Messner C, Behar LC. (eds.). Handbook of oncology social work: psychosocial care of the patient with cancer. New York: Oxford University Press 2015.
20. Winstead E. From scan to scan: the challenges of living with metastatic cancer. [online]. Available from: https: / / www.cancer.gov/ news-events/ cancer-currents-blog/ 2021/ living-with-metastatic-cancer.
21. Pospíchal M, Šporcrová I. Sdělování špatných zpráv pacientům a náročná komunikace v onkologické praxi. Onkologie 2020; 14 (Suppl. C) : 39 – 42. doi: 10.36290/ xon.2020.055.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
